Global Myopia and Presbyopia Treatment Market Table of Contents 1. INTRODUCTION 2. ASSUMPTIONS AND ACRONYMS 3. RESEARCH METHODOLOGY 4. EXECUTIVE SUMMARY - GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET 5. ANALYSIS OF MARKET DYNAMICS 5.1. DRIVERS 5.2. RESTRAINTS 5.3. TRENDS 6. KEY MARKET OPPORTUNITIES 7. INDUSTRY RISK ANALYSIS 7.1. DEMAND RISK ANALYSIS 7.2. SUPPLY RISK ANALYSIS 8. REGULATORY LANDSCAPE 9. IMPACT OF COVID-19 ON MYOPIA & PRESBYOPIA TREATMENT 10. MYOPIA & PRESBYOPIA TREATMENT MARKET OUTLOOK 10.1. MARKET SIZE AND FORECAST, 2018-2028 10.1.1. BY VALUE (USD MILLION) 10.2. MYOPIA & PRESBYOPIA TREATMENT MARKET SEGMENTATION, 2018-2028 10.2.1. BY REGIONS v NORTH AMERICA MYOPIA & PRESBYOPIA TREATMENT MARKET, 2018-2028F (USD MILLION) § MARKET SIZE, 2018-2028F (USD MILLION) § MARKET ANALYSIS § BY COUNTRY o ASSESSMENT OF MACROECONOMIC FACTORS o US & CANADA, 2018-2028F (USD MILLION) v EUROPE MYOPIA & PRESBYOPIA TREATMENT MARKET, 2018-2028F (USD MILLION) § MARKET SIZE, 2018-2028F (USD MILLION) § MARKET ANALYSIS § BY COUNTRY o ASSESSMENT OF MACROECONOMIC FACTORS o UK & GERMANY, 2018-2028F (USD MILLION) o FRANCE & ITALY, 2018-2028F (USD MILLION) o SPAIN & RUSSIA, 2018-2028F (USD MILLION) o REST OF EUROPE, 2018-2028F (USD MILLION) v ASIA PACIFIC MYOPIA & PRESBYOPIA TREATMENT MARKET, 2018-2028F (USD MILLION) § MARKET SIZE, 2018-2028F (USD MILLION) § MARKET ANALYSIS § BY COUNTRY o ASSESSMENT OF MACROECONOMIC FACTORS • CHINA & INDIA, 2018-2028F (USD MILLION) • o JAPAN & SOUTH KOREA, 2018-2028F (USD MILLION) • o AUSTRALIA & MALAYSIA, 2018-2028F (USD MILLION) • o REST OF ASIA PACIFIC, 2018-2028F (USD MILLION) • LATIN AMERICA MYOPIA & PRESBYOPIA TREATMENT MARKET, 2018-2028F (USD MILLION) • MARKET SIZE, 2018-2028F (USD MILLION) • MARKET ANALYSIS • BY COUNTRY • o ASSESSMENT OF MACROECONOMIC FACTORS • o BRAZIL & MEXICO, 2018-2028F (USD MILLION) • o REST OF LATIN AMERICA, 2018-2028F (USD MILLION) • MIDDLE EAST & AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET, 2018-2028F (USD MILLION) • MARKET SIZE, 2018-2028F (USD MILLION) • MARKET ANALYSIS • BY COUNTRY • o ASSESSMENT OF MACROECONOMIC FACTORS • o UNITED ARAB EMIRATES & SAUDI ARABIA, 2018-2028F (USD MILLION) • o ISRAEL & SOUTH AFRICA, 2018-2028F (USD MILLION) • o REST OF MIDDLE EAST & AFRICA, 2018-2028F (USD MILLION) • 11. COMPETITIVE STRUCTURE • 11.1. DETAILED OVERVIEW • 11.2. COMPETITIVE BENCHMARKING • 11.3. ASSESSMENT OF KEY PRODUCT OFFERINGS • 11.4. ANALYSIS OF GROWTH STRATEGIES • 11.5. KEY COLLABORATIONS AND JOINT VENTURES • 11.6. KEY MERGERS AND ACQUISITIONS • 11.7. RECENT NEWS AND DEVELOPMENTS • 11.8. KEY CLIENTS AND PARTNERS • 11.9. EXHAUSTIVE ANALYSIS ON KEY FINANCIAL INDICATORS • 11.10. COMPANY PROFILES • 11.10.1. TOPCON CORPORATION • 11.10.2. ALCON • 11.10.3. BAUSCH & LOMB INCORPORATED • 11.10.4. NIDEK CO., LTD. • 11.10.5. CARL ZEISS AG • 11.10.6. JOHNSON & JOHNSON VISION • 12. STRATEGIC RECOMMENDATIONS |
Growth Drivers
Rising prevalence of myopia and presbyopia is the major factor resulting in the demand for products that are used to treat the conditions. These are highly common ophthalmic conditions which occur among people of all ages. Treatment includes a range of equipment for surgeries such as LASIK and the use of lenses which is expected to boost the demand for the overall market over the forecast period. The usage of lenses is the most commonly used method to manage the disorder, although LASIK surgeries are also gaining significant traction across the globe primarily as a result of rising awareness towards the benefits of long-term solutions. Lenses are available in the form of eyeglasses, contact lenses or intra-ocular lenses out of which eyeglasses are presently the most commonly used product on account of lower price point and less maintenance requirement. Moreover, the growing population above the age of 65 is another significant factor predicted to boost the market growth.
Challenges
Rising healthcare costs which restrict a large section of the population from using these corrective treatment methods is estimated to be a major growth limiting factor for the market. Further, in developing countries, the access to affordable healthcare is limited which is predicted to be another barrier for the market growth over the forecast period.
Base Year |
2023 |
Forecast Year |
2024–2036 |
CAGR |
8.9% |
Base Year Market Size (2023) |
USD 18.72 billion |
Forecast Year Market Size (2036) |
USD 56.71 billion |
Regional Scope |
|
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?